Cargando…

Protease-Activated Receptors – Key Regulators of Inflammatory Bowel Diseases Progression

The pathogenesis and course of inflammatory bowel diseases are related to both immune system disorders and dysfunction of colon permeability. Moreover, co-existing diseases in patients with Crohn’s disease and ulcerative colitis are identified. Currently, there are some therapeutic strategies that a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jacenik, Damian, Fichna, Jakub, Małecka-Wojciesko, Ewa, Mokrowiecka, Anna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8721023/ https://www.ncbi.nlm.nih.gov/pubmed/35002281 http://dx.doi.org/10.2147/JIR.S335502

Ejemplares similares

Sex- and Age-Related Estrogen Signaling Alteration in Inflammatory Bowel Diseases: Modulatory Role of Estrogen Receptors
por: Jacenik, Damian, et al.
Publicado: (2019)

G protein-coupled estrogen receptor mediates anti-inflammatory action in Crohn’s disease
por: Jacenik, Damian, et al.
Publicado: (2019)

Colonic inflammation induces changes in glucose levels through modulation of incretin system
por: Zatorski, Hubert, et al.
Publicado: (2021)

Serum Levels of Chemerin in Patients with Inflammatory Bowel Disease as an Indicator of Anti-TNF Treatment Efficacy
por: Sochal, Marcin, et al.
Publicado: (2021)

The Effect of Serotonin Transmission on Depressive and Insomnia Symptoms in Inflammatory Bowel Diseases
por: Sochal, Marcin, et al.
Publicado: (2023)

The Involvement of the Endogenous Opioid System in the Gastrointestinal Aging in Mice and Humans
por: Szymaszkiewicz, Agata, et al.
Publicado: (2022)

COVID-19 Vaccination in Inflammatory Bowel Disease (IBD)
por: Kubas, Aleksandra, et al.
Publicado: (2022)

Relation between Selected Sleep Parameters, Depression, Anti-Tumor Necrosis Factor Therapy, and the Brain-Derived Neurotrophic Factor Pathway in Inflammatory Bowel Disease
por: Sochal, Marcin, et al.
Publicado: (2023)

Dietary Interventions in Inflammatory Bowel Disease
por: Godala, Małgorzata, et al.
Publicado: (2022)

Dietary Behaviors and Beliefs in Patients with Inflammatory Bowel Disease
por: Godala, Małgorzata, et al.
Publicado: (2023)

Evaluation of Albumin, Transferrin and Transthyretin in Inflammatory Bowel Disease Patients as Disease Activity and Nutritional Status Biomarkers
por: Godala, Małgorzata, et al.
Publicado: (2023)

Significance of G Protein-Coupled Estrogen Receptor in the Pathophysiology of Irritable Bowel Syndrome, Inflammatory Bowel Diseases and Colorectal Cancer
por: Jacenik, Damian, et al.
Publicado: (2020)

Role of Serum Interleukin-6, Interleukin-1β and Interleukin-10 in Assessment of Disease Activity and Nutritional Status in Patients with Inflammatory Bowel Disease
por: Godala, Małgorzata, et al.
Publicado: (2023)

The Expression Pattern of Adhesion G Protein-Coupled Receptor F5 Is Related to Cell Adhesion and Metastatic Pathways in Colorectal Cancer—Comprehensive Study Based on In Silico Analysis
por: Kang, Huining, et al.
Publicado: (2022)

Clinical and Laboratory Characteristics of Anaemia in Hospitalized Patients with Inflammatory Bowel Disease
por: Woźniak, Małgorzata, et al.
Publicado: (2023)

Clinical Significance of Erythroferrone and Bone Morphogenetic Protein-6 in Patients with Anemia in the Course of Inflammatory Bowel Disease
por: Woźniak, Małgorzata, et al.
Publicado: (2023)

Eosinophilic Esophagitis—What Do We Know So Far?
por: Wąsik, Jakub, et al.
Publicado: (2023)

New Class of Anti-Inflammatory Therapeutics Based on Gold (III) Complexes in Intestinal Inflammation–Proof of Concept Based on In Vitro and In Vivo Studies
por: Krajewska, Julia B., et al.
Publicado: (2021)

The incidence of adult type hypolactasia in patients with irritable bowel syndrome
por: Domżał-Magrowska, Danuta, et al.
Publicado: (2023)

The Efficacy of Mebeverine in the Treatment of Irritable Bowel Syndrome—A Systematic Review
por: Daniluk, Jaroslaw, et al.
Publicado: (2022)

A Crosstalk between the Cannabinoid Receptors and Nociceptin Receptors in Colitis—Clinical Implications
por: Wołyniak, Maria, et al.
Publicado: (2022)

Assessment of quality of life in patients with chronic pancreatitis
por: Mokrowiecka, Anna, et al.
Publicado: (2011)

Supplementation of Bovine Colostrum in Inflammatory Bowel Disease: Benefits and Contraindications
por: Sienkiewicz, Michał, et al.
Publicado: (2020)

Simple Serum Pancreatic Ductal Adenocarcinoma (PDAC) Protein Biomarkers—Is There Anything in Sight?
por: Kapszewicz, Monika, et al.
Publicado: (2021)

Pancreatic Incidentaloma
por: Caban, Miłosz, et al.
Publicado: (2022)

Diagnosis and Management of Barrett’s Esophagus
por: Mejza, Maja, et al.
Publicado: (2023)

Modifiable Pancreatic Ductal Adenocarcinoma (PDAC) Risk Factors
por: Michalak, Natalia, et al.
Publicado: (2023)

Review article: the role of oxidative stress in pathogenesis and treatment of inflammatory bowel diseases
por: Piechota-Polanczyk, Aleksandra, et al.
Publicado: (2014)

Focus on current and future management possibilities in inflammatory bowel disease-related chronic pain
por: Zielińska, Anna, et al.
Publicado: (2018)

Influence of the Treatment Used in Inflammatory Bowel Disease on the Protease Activities
por: Dudzińska, Ewa, et al.
Publicado: (2020)

Chitinases and Chitinase-Like Proteins as Therapeutic Targets in Inflammatory Diseases, with a Special Focus on Inflammatory Bowel Diseases
por: Mazur, Marzena, et al.
Publicado: (2021)

Sleep Problems in Chronic Inflammatory Diseases: Prevalence, Treatment, and New Perspectives: A Narrative Review
por: Ditmer, Marta, et al.
Publicado: (2021)

Organometallic Compounds and Metal Complexes in Current and Future Treatments of Inflammatory Bowel Disease and Colorectal Cancer—a Critical Review
por: Szczepaniak, Adrian, et al.
Publicado: (2019)

Association between brain-derived neurotrophic factor and symptoms of insomnia and depression in inflammatory bowel disease (IBD) patients
por: Sochal, M., et al.
Publicado: (2021)

Targeting Histamine Receptors in Irritable Bowel Syndrome: A Critical Appraisal
por: Fabisiak, Adam, et al.
Publicado: (2017)

Leukocytapheresis in patients with inflammatory bowel diseases
por: Woźniak, Małgorzata, et al.
Publicado: (2021)

AdipoRon, an Orally Active, Synthetic Agonist of AdipoR1 and AdipoR2 Receptors Has Gastroprotective Effect in Experimentally Induced Gastric Ulcers in Mice
por: Zatorski, Hubert, et al.
Publicado: (2021)

The Latest Advancements in Diagnostic Role of Endosonography of Pancreatic Lesions
por: Rogowska, Jagoda Oliwia, et al.
Publicado: (2023)

Expression of FFAR3 and FFAR4 Is Increased in Gastroesophageal Reflux Disease
por: Fabisiak, Adam, et al.
Publicado: (2020)

Oxidative Stress Does Not Influence Subjective Pain Sensation in Inflammatory Bowel Disease Patients
por: Zielińska, Anna Krystyna, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_pgrdk53itdoikegddolkji8ruq